MedPath

Management of Obstructive Colon Tumors in Istanbul

Conditions
Colon Cancer
Tumor Obstruction
Emergencies
Quality of Life
Registration Number
NCT05424939
Lead Sponsor
Istanbul Medipol University Hospital
Brief Summary

The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
500
Inclusion Criteria
  • Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected
  • Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT
Exclusion Criteria
  • Benign diseases
  • Emergency surgery due to bleeding, perforation and other non-obstructive situations
  • Recurrent colon tumors
  • Rectal cancer

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Time-to-starting chemotherapy1 year

Surgical procedures will be compared in terms of days-to-first chemotherapy

Secondary Outcome Measures
NameTimeMethod
Morbidity3 months

90-day morbidity

Colorectal cancer-specific quality of life (EORTC QLQ - CR29) at 1 year1 year

The European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Colorectal Cancer (EORTC QLQ-CR29) scale will be recorded preoperatively and at 12 months. Surgical procedures will be compared in terms of improvement in EORTC QLQ-CR29 scores.

Mortality3 months

90-day mortality

Trial Locations

Locations (2)

Medipol University Bahcelievler Hospital

🇹🇷

Istanbul, Turkey

Medipol Mega Hospital

🇹🇷

Istanbul, Turkey

© Copyright 2025. All Rights Reserved by MedPath